{"organizations": [], "uuid": "eeeb585a5f145e933878a9f0438a05a2f9c9579a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://si.wsj.net/public/resources/images/BN-XA300_3gjvL_TOP_20180116161734.jpg", "site_section": "https://www.wsj.com/europe", "section_title": "The Wall Street Journal &amp; Breaking News, Business, Financial and Economic News, World News and Video", "url": "https://www.wsj.com/articles/judge-signals-he-will-approve-290-million-settlement-between-allergan-shareholders-and-pershing-valeant-1516138953", "country": "US", "domain_rank": 387, "title": "Judge Signals He Will Approve $290 Million Settlement Between Allergan Shareholders and Pershing, Valeant", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.798, "site_type": "news", "published": "2018-01-17T02:02:00.000+02:00", "replies_count": 0, "uuid": "eeeb585a5f145e933878a9f0438a05a2f9c9579a"}, "author": "David Benoit", "url": "https://www.wsj.com/articles/judge-signals-he-will-approve-290-million-settlement-between-allergan-shareholders-and-pershing-valeant-1516138953", "ord_in_thread": 0, "title": "Judge Signals He Will Approve $290 Million Settlement Between Allergan Shareholders and Pershing, Valeant", "locations": [], "entities": {"persons": [{"name": "pershing squa", "sentiment": "negative"}], "locations": [{"name": "pershing", "sentiment": "none"}, {"name": "pershing square", "sentiment": "none"}, {"name": "valeant", "sentiment": "none"}], "organizations": [{"name": "allergan plc", "sentiment": "none"}, {"name": "capital management", "sentiment": "none"}, {"name": "valeant pharmaceuticals international inc.", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "A federal judge signaled Tuesday he would approve a $290 million settlement reached by Pershing Square Capital Management, Valeant Pharmaceuticals International Inc. and the shareholders of Allergan PLC who had alleged the two firms improperly profited from their failed attempt to buy the maker of Botox.\nIn a hearing Tuesday, the judge also said he intended to publicly issue a final version of a tentative opinion he had privately issued last month that rejected two key legal arguments Pershing Square and Valeant had made.... ", "external_links": [], "published": "2018-01-17T02:02:00.000+02:00", "crawled": "2018-01-17T04:30:11.013+02:00", "highlightTitle": ""}